scispace - formally typeset
A

Awanti Sambarey

Researcher at Indian Institute of Science

Publications -  10
Citations -  191

Awanti Sambarey is an academic researcher from Indian Institute of Science. The author has contributed to research in topics: In vivo & Drug. The author has an hindex of 6, co-authored 9 publications receiving 133 citations. Previous affiliations of Awanti Sambarey include University of Michigan.

Papers
More filters
Journal ArticleDOI

Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks.

TL;DR: A computational pipeline is described that adopts an unbiased approach to identify a biomarker signature comprising 10 genes that can discriminate between TB and healthy controls as well as distinguish TB from latent tuberculosis and HIV in most cases.
Journal ArticleDOI

Meta-analysis of host response networks identifies a common core in tuberculosis.

TL;DR: A meta-analysis of host’s whole blood transcriptomic profiles that were integrated into a genome-scale protein–protein interaction network to generate response networks in active tuberculosis, and reports the emergence of a highly active common core in disease, showing partial reversals upon treatment.
Journal ArticleDOI

Mining large-scale response networks reveals ‘topmost activities’ in Mycobacterium tuberculosis infection

TL;DR: This work constructs a comprehensive network of infection-related processes in a human macrophage comprising 1888 proteins and 14,016 interactions and uses a novel formulation for mining response networks that has led to identifying highest activities in the cell.
Journal ArticleDOI

High IL-6 and low IL-15 levels mark the presence of TB infection: A preliminary study.

TL;DR: The study concludes that altered balance in the levels of serum cytokines can be indicative of TB pathogenesis and profiling of dynamic changes in cytokines would facilitate effective TB diagnostic and treatment strategies.
Journal ArticleDOI

A multi-scale pipeline linking drug transcriptomics with pharmacokinetics predicts in vivo interactions of tuberculosis drugs.

TL;DR: In this paper, a machine learning model, INDIGO-MTB, was used to predict in vitro drug interactions using drug transcriptomics, with a multi-scale model of drug PK/PD and pathogen-immune interactions called GranSim.